(RTTNews) - Indian shares tumbled on Friday to extend losses from the previous session as investors fretted about the impact AI could have on revenues and profit margins of financial, transportation and logistics and even commercial real estate companies.
(RTTNews) - Indian shares tumbled on Friday to extend losses from the previous session as investors fretted about the impact AI could have on revenues and profit margins of financial, transportation and logistics and even commercial real estate companies.
Garlic occupies a unique position in Chinese wedding traditions and broader cultural beliefs. In parts of Guangdong province, brides traditionally include garlic in their dowries, as it is believed to ward off evil spirits, dispel negative energy, and enhance feng shui in southern China. China stands as the largest producer and consumer of garlic globally, which serves as a foundational aromatic i...
Garlic occupies a unique position in Chinese wedding traditions and broader cultural beliefs. In parts of Guangdong province, brides traditionally include garlic in their dowries, as it is believed to ward off evil spirits, dispel negative energy, and enhance feng shui in southern China. China stands as the largest producer and consumer of garlic globally, which serves as a foundational aromatic ingredient, alongside ginger and spring onions, in most regional Chinese cuisines. In traditional...
Donny DBM/iStock via Getty Images Market Recap Global equity markets closed out 2025 on a strong note, with international equities delivering their widest annual outperformance versus U.S. equities since the Great Financial Crisis (GFC). A weakening dollar, narrowing rate differentials, and attractive relative valuations all contributed to the reversal. A significant de-escalation in U.S.-China tr...
Donny DBM/iStock via Getty Images Market Recap Global equity markets closed out 2025 on a strong note, with international equities delivering their widest annual outperformance versus U.S. equities since the Great Financial Crisis (GFC). A weakening dollar, narrowing rate differentials, and attractive relative valuations all contributed to the reversal. A significant de-escalation in U.S.-China trade tensions provided additional relief and supported risk-on sentiment. Meanwhile, central bank policy paths diverged—the Federal Reserve (Fed) continued easing, the European Central Bank (ECB) held steady, and the Bank of Japan (BOJ) raised rates to their highest level in nearly three decades. The fourth quarter proved challenging for our international portfolios as several themes that had contributed positively earlier in the year reversed sharply. Our Greater China holdings gave back a portion of their substantial gains amid profit-taking, though they remained additive to full-year performance. Value and cyclical leadership persisted, and we had no exposure to European or Japanese banks or to materials, where commodities rallied on AI-related infrastructure demand and precious metals prices. Within information technology, the market's enthusiasm for AI-related hardware contrasted sharply with weakness in application software and IT services, where concerns about potential disruption weighed on valuations. And in health care, company-specific concerns weighed on two of our holdings. While this environment did not favor our quality growth approach, our investment philosophy remains unchanged. Our concentrated, conviction-weighted portfolios are designed to outperform market growth rates over an investment cycle. We prioritize businesses that align with secular trends and have strong competitive advantages and market positions. Our portfolio companies are chosen for their high profit margins, strong balance sheets, and consistent cash generation. We believe these qualities...
BeOne Medicines AG (NASDAQ:ONC) is one of the High Growth International Stocks to Buy Now. On February 9, Rebecca Liang from Bernstein reiterated a Buy rating on the stock with a $414 price target. Earlier, on February 4, Barclays also reiterated a Buy rating on BeOne Medicines AG (NASDAQ:ONC) and raised the price target from […]
BeOne Medicines AG (NASDAQ:ONC) is one of the High Growth International Stocks to Buy Now. On February 9, Rebecca Liang from Bernstein reiterated a Buy rating on the stock with a $414 price target. Earlier, on February 4, Barclays also reiterated a Buy rating on BeOne Medicines AG (NASDAQ:ONC) and raised the price target from […]
hapabapa/iStock Editorial via Getty Images Even though I am a value investor at heart, I am not necessarily opposed to growth prospects. But the price that I pay for that growth had better be appropriate. Otherwise, the opportunity in question is a pass. This has resulted in me avoiding significant losses in the past. But at the same time, one downside has been that I sometimes take a more cautiou...
hapabapa/iStock Editorial via Getty Images Even though I am a value investor at heart, I am not necessarily opposed to growth prospects. But the price that I pay for that growth had better be appropriate. Otherwise, the opportunity in question is a pass. This has resulted in me avoiding significant losses in the past. But at the same time, one downside has been that I sometimes take a more cautious approach to a company only to see the share price rise drastically. A good example of this can be seen by looking at Dutch Bros ( BROS ), a drive-thru shop owner that focuses on beverage sales. Back in September of 2023, I wrote my first-ever article about the business. I called it a solid prospect for growth investors. However, the price was too high to justify anything other than a neutral outlook for me. Since rating the company a 'hold' back then, the stock has jumped 84.1%. That's well above the 52.5% increase that the S&P 500 saw over the same window of time. And this doesn't even include the 12.3% jump that the stock saw after the market closed on February 12th. This surge higher came after management announced financial results for the final quarter of the company's 2025 fiscal year. Revenue, earnings per share, and adjusted earnings per share, all came in above what analysts were hoping to see. This is great in and of itself. But still, even with this and even with the promise from management of additional growth over the next couple of years, shares are priced at levels that are difficult to get behind. Because of the rapid expansion that we are seeing, I won't go so far as to take a bearish stance on the business. But I do think that a cautious 'hold' rating makes the most sense here. A great quarter Author - SEC EDGAR Data By all accounts, the final quarter of the 2025 fiscal year was a good time for shareholders of Dutch Bros. Revenue for the business came in at $443.6 million. That's well above the $342.8 million the company reported a year earlier. And it a...